The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 22, 2016
Filed:
Apr. 03, 2012
Applicants:
Trond Ulven, Copenhagen K, DK;
Elisabeth Christiansen, Odense M, DK;
Inventors:
Trond Ulven, Copenhagen K, DK;
Elisabeth Christiansen, Odense M, DK;
Assignee:
CALDAN THERAPEUTICS LIMITED, Glasgow, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 57/60 (2006.01); C07C 255/57 (2006.01); C07C 317/44 (2006.01); C07C 51/353 (2006.01); C07C 51/367 (2006.01); C07C 253/30 (2006.01); C07C 315/04 (2006.01); C07C 255/41 (2006.01); C07C 59/56 (2006.01);
U.S. Cl.
CPC ...
C07C 57/60 (2013.01); C07C 51/353 (2013.01); C07C 51/367 (2013.01); C07C 59/56 (2013.01); C07C 253/30 (2013.01); C07C 255/41 (2013.01); C07C 255/57 (2013.01); C07C 315/04 (2013.01); C07C 317/44 (2013.01);
Abstract
There is provided novel fluoro-substituted compounds capable of modulating the G-protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions such as type II diabetes, hypertension, ketoacidosis, obesity, glucose intolerance, and hypercholesterolemia and related disorders associated with abnormally high or low plasma lipoprotein, triglyceride or glucose levels.